# Contrast Enhanced 3D Echocardiographic Quantification of Right Ventricular Volumes in Repaired CHD

> **NCT05186415** · PHASE1,PHASE2 · COMPLETED · sponsor: **Nemours Children's Clinic** · enrollment: 25 (actual)

## Conditions studied

- Tetralogy of Fallot
- Pulmonary Insufficiency

## Interventions

- **DRUG:** Sulfur Hexafluoride Lipid Type A Microspheres 25 MG Injection Powder for Suspension [LUMASON]

## Key facts

- **NCT ID:** NCT05186415
- **Lead sponsor:** Nemours Children's Clinic
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-08-23
- **Primary completion:** 2024-06-25
- **Final completion:** 2024-06-25
- **Target enrollment:** 25 (ACTUAL)
- **Last updated:** 2026-04-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05186415

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05186415, "Contrast Enhanced 3D Echocardiographic Quantification of Right Ventricular Volumes in Repaired CHD". Retrieved via AI Analytics 2026-07-13 from https://api.ai-analytics.org/clinical/NCT05186415. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*